As of Jun 21
| -3.05 / -5.51%|
The 6 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 78.50, with a high estimate of 146.00 and a low estimate of 70.00. The median estimate represents a +49.95% increase from the last price of 52.35.
The current consensus among 6 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.